Loading...
•
Apr 03, 2021
Plexus Q2 2021 Earnings Report
Announced fiscal second quarter financial results.
Key Takeaways
Plexus reported fiscal second quarter revenue of $881 million and GAAP diluted EPS of $1.42. The company initiated fiscal third quarter 2021 revenue guidance of $875 to $915 million with GAAP diluted EPS guidance of $1.23 to $1.38, excluding any unforeseen COVID-19 impacts.
Won 42 manufacturing programs during the quarter representing $284 million in annualized revenue when fully ramped into production.
Trailing four quarter wins total a record $1.044 billion in annualized revenue when fully ramped into production.
GAAP operating margin of 5.75% expanded 11 basis points from the prior quarter, representing the best performance in more than a decade.
Return on invested capital of 17.3%, sequentially improved by 100 basis points and the highest return delivered in four years.
Plexus
Plexus
Forward Guidance
The company anticipates robust performance will continue for the fiscal third quarter based upon incrementally stronger demand, particularly in our Healthcare/Life Sciences sector, and confidence in our ability to consistently execute.
Positive Outlook
- Revenue of $875 to $915 million
- GAAP operating margin of 5.1% to 5.6%
- GAAP EPS of $1.23 to $1.38
- Incrementally stronger demand
- Confidence in ability to consistently execute
Challenges Ahead
- Supply chain constraints are a near term limiter in our ability to meet customer demand upside
- COVID-19 will materially impact end markets or our operations beyond what is already anticipated
- unforeseen COVID-19 impacts
- Potential customer delays
- Changes in governmental actions